Greg Tourangeau insider trades
Open-market stock purchases and sales by Greg Tourangeau, Principal Accounting Officer at Fulcrum Therapeutics, Inc, from SEC Form 4 filings since May 6, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 2, 2026 | FULC Fulcrum Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- FULC Fulcrum Therapeutics, Inc: 4 sales, last Feb 2, 2026